Profil
Jack L.
Bowman is the founder of Reliant Pharmaceuticals LLC, which was founded in 1999.
He served as Chairman & Chief Executive Officer of Poniard Pharmaceuticals, Inc. He was Group Chairman at Johnson & Johnson from 1987 to 1994.
He also served as Chairman of Sarepta Therapeutics, Inc. from 2004 to 2008.
Bowman was a Director at Celgene Corp.
and Cellegy Pharmaceuticals, Inc. He was also a Director at AmpliPhi Biosciences Corp.
from 1997 to 2008 and at CTI BioPharma Corp.
from 1995 to 2004.
Bowman was Executive Vice President at Wyeth Holdings LLC from 1983 to 1987.
Ehemalige bekannte Positionen von Jack L. Bowman
| Unternehmen | Position | Ende |
|---|---|---|
Cellegy Pharmaceuticals, Inc.
Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs and cosmetic products | Direktor/Vorstandsmitglied | 22.04.2009 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Direktor/Vorstandsmitglied | 15.05.2008 |
| SAREPTA THERAPEUTICS, INC. | Vorsitzender | 10.03.2008 |
| CTI BIOPHARMA CORP. | Direktor/Vorstandsmitglied | 21.05.2004 |
| JOHNSON & JOHNSON | Vorsitzender | 01.01.1994 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Cellegy Pharmaceuticals, Inc.
Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs and cosmetic products | Health Technology |
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















